Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
26 October, 2014 11:27 IST
News
Dr Reddys gets USFDA nod for Sildenafil tablets
Source: IRIS | 19 Nov, 2012, 09.43AM
Comments  |  Post Comment

Dr Reddys Laboratories, an integrated global pharmaceutical company,  announced that it has launched Sildenafil tablets (20 mg), a bioequivalent generic version of Revatio (Sildenafil) tablets in the US market.

It has received approval by the United States Food & Drugs Administration (USFDA) for ANDA Sildenafil tablets.

The Revatio brand had US sales of approximately USD 338.67 million for the most recent 12 months ending September 2012 according to IMS health.

Shares of the company gained Rs 16, or 0.91%, to trade at Rs 1,773.35. The total volume of shares traded was 755 at the BSE (9.32 a.m., Monday).



Dr Reddy`S Laboratories Limited   (Q,N,C,F)*


Live News
Cheerful start to Samvat 2071:Sensex ends 63 points higher; Nifty reclaims 8,000 - 23-Oct-2014 20:06
Unitil Corp third-quarter profit jumps - 23-Oct-2014 19:28
Mobile Mini third-quarter profit rises marginally - 23-Oct-2014 19:16
Zimmer Holdings third quarter earnings climb - 23-Oct-2014 19:15
Meredith Corp first-quarter profit rises - 23-Oct-2014 19:09
Celgene Corp third-quarter profit surges - 23-Oct-2014 19:03
Sonus Networks third-quarter loss widens - 23-Oct-2014 19:03
Northwestern Corp third-quarter profit almost doubles - 23-Oct-2014 18:57
Gatx Corp third-quarter earnings drop - 23-Oct-2014 18:52
Life Time Fitness third quarter profit stands flat - 23-Oct-2014 18:45
Carpenter Technology first-quarter earnings plunge - 23-Oct-2014 18:44
more...
* Q - Quote , N - News , C - Chart , F - Financials
Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type   745rnw into this box
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer